In a bid to bolster its footing in providing surgical treatments, Johnson & Johnson has announced it will acquire robotics specialist Auris Health via its subsidiary Ethicon in a deal worth potentially $5.75 million in cash.
This total value breaks down into an upfront cash payment of $3.4 billion and $2.35 billion in milestone payments.
